336 results on '"Möttönen, T."'
Search Results
2. Defining the anterior nucleus of the thalamus (ANT) as a deep brain stimulation target in refractory epilepsy: Delineation using 3 T MRI and intraoperative microelectrode recording
3. Reduction in Clostridium difficile infections in Finland, 2008–2010
4. Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005
5. Venture Capital -rahastojen exit-menetelmät
6. Many-body Majorana-like zero modes without gauge symmetry breaking
7. The reduction of physical activity reflects on the bone mass among young females: a follow-up study of 142 adolescent girls
8. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.
9. Association of Reduced Physical Activity and Quantitative Ultrasound Measurements: A 6-Year Follow-up Study of Adolescent Girls
10. The effect of conventional vitamin D2 supplementation on serum 25(OH)D concentration is weak among peripubertal Finnish girls: a 3-y prospective study
11. Influence of Physical Activity and Cessation of Training on Calcaneal Quantitative Ultrasound Measurements in Peripubertal Girls: A 1-Year Prospective Study
12. Influence of Physical Activity on Ultrasound and Dual-Energy X-ray Absorptiometry Bone Measurements in Peripubertal Girls: A Cross-Sectional Study
13. Vitamin D intake is low and hypovitaminosis D common in healthy 9− to 15-year-old Finnish girls
14. Benchmarking antibiotic use in Finnish acute care hospitals using patient case-mix adjustment
15. Exercise-induced training effects on bone mineral content: a 7-year follow-up study with adolescent female gymnasts and runners
16. Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis
17. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trial
18. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis: Authors’ reply
19. How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience
20. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study
21. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis
22. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis
23. Diagnostic delay and induction of remission by using single-drug or combination drug therapy strategy with DMARDs
24. Differences between female and male patients with familial rheumatoid arthritis
25. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis
26. Defining the anterior nucleus of the thalamus (ANT) as a deep brain stimulation target in refractory epilepsy: Delineation using 3 T MRI and intraoperative microelectrode recording
27. Päiväkotien toimintakulttuurien yhteys työntekijöiden äänihäiriöihin
28. Serum ferritin and free erythrocyte protoporphyrin in rheumatoid arthritis
29. Clinical sequelae and sacroiliac joint changes by computed tomography after recovery from septic sacroiliitis
30. Glutathione and selenium in rheumatoid arthritis
31. FRI0254 Predictive Value of Pretreatment Resistin Levels for Erosive Disease in Early RA Treated with DMARDS and Infliximab
32. FRI0540 A nation-wide review of patients with rheumatoid arthritis in finland
33. OP0147 Targeted treatment with combination DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of the neo-raco trial
34. SAT0026 Targeted Treatment and Combination Dmard Therapy are Additively Important for Reaching Remission in Early Rheumatoid Arthritis
35. SAT0027 Targeted Treatment and Combination Dmard Therapy are Additively Important for Maintaining Work Ability in Early Rheumatoid Arthritis
36. Consistency of assessments and willingness to pay for a reduction in morning symptoms over time in patients with rheumatoid arthritis
37. How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?
38. Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000–2007
39. Markers of bone turnover in peripubertal girls
40. Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients
41. Exercise-induced training effects on bone mineral content: a 7-year follow-up study with adolescent female gymnasts and runners
42. Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN‐RACo trial
43. OA1 QUALITY OF LIFE IN EARLY RHEUMATOID ARTHRITIS TREATED WITH COMBINATION VS. SINGLE DRUG THERAPY-RESULTS FROM FIN-RACO TRIAL
44. P17.80 Use of Antimicrobials in Finnish Acute Care Hospitals - Data from National Prevalence Survey, 2005
45. Reactive oligoarthritis associated with Clostridium difficile colitis.
46. Scintigraphy of rheumatoid peripheral joints. Reliability of visual assessment vs. computerized methods.
47. Urinary neopterin index as a measure of rheumatoid activity.
48. AB0027 Tnf-alfa responses induced by different enterobacteria and gram-positive cell walls of normal intestinal microbiota in early rheumatoid arthritis
49. Follow-up study of the effect of a three-month course of ciprofloxacin on the late prognosis of reactive arthritis
50. Detection of bacterial components in synovial tissue from patients with inflammatory arthritis by using PCR with pan bacterial 23S rRNA and 16S rRNA primers, and gas chromatography-mass spectrometry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.